309 related articles for article (PubMed ID: 24270418)
21. LMP1-positive extracellular vesicles promote radioresistance in nasopharyngeal carcinoma cells through P38 MAPK signaling.
Zhang Z; Yu X; Zhou Z; Li B; Peng J; Wu X; Luo X; Yang L
Cancer Med; 2019 Oct; 8(13):6082-6094. PubMed ID: 31436393
[TBL] [Abstract][Full Text] [Related]
22. Dual PI3K/mTOR inhibitors, GSK2126458 and PKI-587, suppress tumor progression and increase radiosensitivity in nasopharyngeal carcinoma.
Liu T; Sun Q; Li Q; Yang H; Zhang Y; Wang R; Lin X; Xiao D; Yuan Y; Chen L; Wang W
Mol Cancer Ther; 2015 Feb; 14(2):429-39. PubMed ID: 25504751
[TBL] [Abstract][Full Text] [Related]
23. mTORC2-mediated PDHE1α nuclear translocation links EBV-LMP1 reprogrammed glucose metabolism to cancer metastasis in nasopharyngeal carcinoma.
Zhang J; Jia L; Liu T; Yip YL; Tang WC; Lin W; Deng W; Lo KW; You C; Lung ML; Lung HL; Cheung AL; Tsao SW; Tsang CM
Oncogene; 2019 Jun; 38(24):4669-4684. PubMed ID: 30745576
[TBL] [Abstract][Full Text] [Related]
24. Hsa-miR-24-3p increases nasopharyngeal carcinoma radiosensitivity by targeting both the 3'UTR and 5'UTR of Jab1/CSN5.
Wang S; Pan Y; Zhang R; Xu T; Wu W; Zhang R; Wang C; Huang H; Calin CA; Yang H; Claret FX
Oncogene; 2016 Nov; 35(47):6096-6108. PubMed ID: 27157611
[TBL] [Abstract][Full Text] [Related]
25. Twist1 promotes radioresistance in nasopharyngeal carcinoma.
Zhang L; Su B; Sun W; Li W; Luo M; Liu D; Mei Q; Long G; Hu G; Hu G
Oncotarget; 2016 Dec; 7(49):81332-81340. PubMed ID: 27793033
[TBL] [Abstract][Full Text] [Related]
26. mTOR activation in immature cells of primary nasopharyngeal carcinoma and anti-tumor effect of rapamycin in vitro and in vivo.
Yang C; Peng J; Jiang W; Zhang Y; Chen X; Wu X; Zhu Y; Zhang H; Chen J; Wang J; Cho WC; Jin K
Cancer Lett; 2013 Dec; 341(2):186-94. PubMed ID: 23933173
[TBL] [Abstract][Full Text] [Related]
27. Role of leukemia inhibitory factor in nasopharyngeal carcinogenesis.
Liu SC; Chang YS
Mol Cell Oncol; 2014; 1(1):e29900. PubMed ID: 27308310
[TBL] [Abstract][Full Text] [Related]
28. RPA1 downregulation enhances nasopharyngeal cancer radiosensitivity via blocking RAD51 to the DNA damage site.
Zhang Z; Huo H; Liao K; Wang Z; Gong Z; Li Y; Liu C; Hu G
Exp Cell Res; 2018 Oct; 371(2):330-341. PubMed ID: 30144445
[TBL] [Abstract][Full Text] [Related]
29. EBV-LMP1 promotes radioresistance by inducing protective autophagy through BNIP3 in nasopharyngeal carcinoma.
Xu S; Zhou Z; Peng X; Tao X; Zhou P; Zhang K; Peng J; Li D; Shen L; Yang L
Cell Death Dis; 2021 Apr; 12(4):344. PubMed ID: 33795637
[TBL] [Abstract][Full Text] [Related]
30. EBV encoded miRNA BART8-3p promotes radioresistance in nasopharyngeal carcinoma by regulating ATM/ATR signaling pathway.
Zhou X; Zheng J; Tang Y; Lin Y; Wang L; Li Y; Liu C; Wu D; Cai L
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31471531
[TBL] [Abstract][Full Text] [Related]
31. EBV‑LMP1 is involved in vasculogenic mimicry formation via VEGFA/VEGFR1 signaling in nasopharyngeal carcinoma.
Xu S; Bai J; Zhuan Z; Li B; Zhang Z; Wu X; Luo X; Yang L
Oncol Rep; 2018 Jul; 40(1):377-384. PubMed ID: 29749553
[TBL] [Abstract][Full Text] [Related]
32. Mitogen- and stress-activated Kinase 1 mediates Epstein-Barr virus latent membrane protein 1-promoted cell transformation in nasopharyngeal carcinoma through its induction of Fra-1 and c-Jun genes.
Li B; Wan Z; Huang G; Huang Z; Zhang X; Liao D; Luo S; He Z
BMC Cancer; 2015 May; 15():390. PubMed ID: 25958199
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis.
Huang T; Yin L; Wu J; Gu JJ; Wu JZ; Chen D; Yu HL; Ding K; Zhang N; Du MY; Qian LX; Lu ZW; He X
J Exp Clin Cancer Res; 2016 Dec; 35(1):188. PubMed ID: 27919278
[TBL] [Abstract][Full Text] [Related]
34. Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy.
Xiao L; Hu ZY; Dong X; Tan Z; Li W; Tang M; Chen L; Yang L; Tao Y; Jiang Y; Li J; Yi B; Li B; Fan S; You S; Deng X; Hu F; Feng L; Bode AM; Dong Z; Sun LQ; Cao Y
Oncogene; 2014 Sep; 33(37):4568-78. PubMed ID: 24662831
[TBL] [Abstract][Full Text] [Related]
35. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
[TBL] [Abstract][Full Text] [Related]
36. VEGF knockdown enhances radiosensitivity of nasopharyngeal carcinoma by inhibiting autophagy through the activation of mTOR pathway.
Chen L; Lin G; Chen K; Wan F; Liang R; Sun Y; Chen X; Zhu X
Sci Rep; 2020 Oct; 10(1):16328. PubMed ID: 33004943
[TBL] [Abstract][Full Text] [Related]
37. Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study.
Rosales-Pérez S; Cano-Valdez AM; Flores-Balcázar CH; Guedea-Edo F; Lino-Silva LS; Lozano-Borbalas A; Navarro-Martín A; Poitevin-Chacón A
Arch Med Res; 2014 Apr; 45(3):229-36. PubMed ID: 24606815
[TBL] [Abstract][Full Text] [Related]
38. FGF8b oncogene mediates proliferation and invasion of Epstein-Barr virus-associated nasopharyngeal carcinoma cells: implication for viral-mediated FGF8b upregulation.
Lui VW; Yau DM; Cheung CS; Wong SC; Chan AK; Zhou Q; Wong EY; Lau CP; Lam EK; Hui EP; Hong B; Hui CW; Chan AS; Ng PK; Ng YK; Lo KW; Tsang CM; Tsui SK; Tsao SW; Chan AT
Oncogene; 2011 Mar; 30(13):1518-30. PubMed ID: 21119603
[TBL] [Abstract][Full Text] [Related]
39. Targeting EBV-LMP1 DNAzyme enhances radiosensitivity of nasopharyngeal carcinoma cells by inhibiting telomerase activity.
Yang L; Xu Z; Liu L; Luo X; Lu J; Sun L; Cao Y
Cancer Biol Ther; 2014 Jan; 15(1):61-8. PubMed ID: 24145206
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of endocan by Epstein-Barr virus latent membrane protein 1 and its clinical significance in nasopharyngeal carcinoma.
Yu PH; Chou SF; Chen CL; Hung H; Lai CY; Yang PM; Jeng YM; Liaw SF; Kuo HH; Hsu HC; Chen JY; Wang WB
PLoS One; 2013; 8(12):e82254. PubMed ID: 24340011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
